baber/WOPTO huggingface dataset:
Patent MX-2019010636-A (MX)
Title: Resource allocation method, network device and terminal device.
Inventor: HAI TANG
IPC: H04W72/04
Filed: 2018-08-01
Abstract: The present application relates to a resource allocation method, a network device and a terminal device. The method comprises: a network device allocates a plurality of receiving resource pools corresponding to different synchronisation reference sources for a terminal device, the plurality of receiving resource pools being used for the terminal device to receive data sent by another terminal device; the network device determines at least one receiving resource pool from among the plurality of receiving resource pools; the network device sends a system information block (SIB) to the terminal device, the SIB being used for indicating the at least one receiving resource pool. The network device configures the plurality of receiving resource pools for the terminal device, determines the at least one receiving resource pool from among the plurality of receiving resource pools, and indicates the at least one receiving resource pool via the SIB, so as to avoid SIB size limitation, and thereby implement flexible receiving resource pool configuration.
Patent MX-2019010761-A (MX)
Title: Interlayer for laminated glass, method for producing interlayer for laminated glass, and laminated glass.
Inventor: KAZUHIKO NAKAYAMA
IPC: C03C27/12
Filed: 2018-03-28
Abstract: The purpose of the present invention is to provide: an interlayer for laminated glass capable of producing laminated glass having high visible-light transmittance even when degassing during preliminary press bonding and heating during main press bonding are conducted in parallel in vacuum degassing; a method for manufacturing said interlayer for laminated glass; and interlayer for laminated glass in which said interlayer for laminated glass is used. The present invention is an interlayer for laminated glass having a large number of recesses on at least one side thereof wherein the surface having the recesses of the interlayer for laminated glass has a surface texture ratio Str measured in accordance with ISO 25178 of 0.04 or lower.
Patent MX-2019010941-A (MX)
Title: Antigen receptors and uses thereof.
Inventor: PETRA SIMON
IPC: C07K14/725
Filed: 2018-03-14
Abstract: The present invention generally embraces the treatment of diseases by targeting cells expressing an antigen on the cell surface. In particular the invention relates to recombinant antigen receptors and uses thereof. T cells engineered to express such antigen receptors are useful in the treatment of diseases characterized by expression of one or more antigens bound by the antigen receptors.
Patent MX-2019012964-A (MX)
Title: In-body perfusion system.
Inventor: CARLO ANDRETTA
IPC: A61M5/172
Filed: 2018-05-02
Abstract: An implantable perfusion device (2) comprises a tubular transmission line (4) with an inlet end (6), an outlet end (8) and a flow restriction element (10) located therebetween, whereby an inlet section (12) of the transmission line is defined between the inlet end and the flow restriction element and whereby an outlet section (14) of the transmission line is defined between the flow restriction element and the outlet end. Moreover, the device comprises a perfusion chamber (16) containing a load of biologically active cells and is provided with a fluid entrance (18), a fluid exit (20) and a chamber volume (22) formed therebetween. The fluid entrance comprises at least one first microchannel platelet (24) and the fluid exit comprises at least one second microchannel platelet (26), each one of the microchannel platelets comprising at least one array of microchannels (28) defining a fluid passage between respective external and internal platelet faces, the microchannels having an opening of 0.2 to 10 µm. The fluid entrance (18) of the perfusion chamber is in fluid communication with the inlet section (12) of the transmission line; and the flow restriction element (10) is configured to establish a predetermined pressure excess in the inlet section (12) versus the outlet section (14).
Patent MX-2019015593-A (MX)
Title: Interior gallery for practicing shooting with a rifle or pistol.
Inventor: GARZA CARDOZA MARIO ROBERTO
IPC: F41J11/00
Filed: 2019-12-19
Abstract: The present invention relates to an indoor shooting gallery for practicing pistol or rifle shooting in single or multi-player mode, consisting of one or more shooting positions or balconies for short or long-range weapons operated by compressed air. Herein, each balcony has a shooting rack locating a plurality of silhouettes in an arrangement of rows per column with sensors installed, detecting when a shooter hits, sending a signal to the media of control, and recording the score. Also, the software counts the successes presenting the performance in a graphic interface in a terminal of the shooter's side, and the gallery administrator repositioned the hit pieces at the end of each turn by pneumatic means.
Patent MX-2020001230-A (MX)
Title: Carrier for containers.
Inventor: HOLLEY JR JOHN MURDICK
IPC: B65D71/58
Filed: 2018-07-26
Abstract: A carrier for holding at least one container includes a plurality of panels extending at least partially around an interior of the carrier, the plurality of panels includes a front panel, a back panel, at least one central panel, at least one side panel, and at least one bottom panel. At least one divider flap is foldably connected to one of the front panel and the back panel, the at least one divider flap folded away from the one of the front panel and the back panel to form at least one opening in the one of the front panel and the back panel, the at least one divider flap extends through the interior of the carrier to the at least one central panel.
Patent MX-2020001342-A (MX)
Title: Use of gaboxadol in the treatment of diabetes and related conditions.
Inventor: DURING MATTHEW
IPC: A61K9/00
Filed: 2018-08-02
Abstract: Methods and compositions for treating a metabolic disease include administering gaboxadol or a pharmaceutically acceptable salt thereof to a patient diagnosed with a metabolic disease. In embodiments, administering gaboxadol or a pharmaceutically acceptable salt thereof to a patient diagnosed with a metabolic disease is effective to lower one or more of HbA1c level, fasting plasma glucose level, 2-hour oral glucose tolerance test (OGTT) result level, and random plasma glucose level. Gaboxadol or a pharmaceutically acceptable salt thereof may optionally be administered in combination with a hypoglycemic agent.
Patent MX-2020002574-A (MX)
Title: Transport device and transport method having such a transport device.
Inventor: SCHOLZ ULRICH
IPC: B65G23/18
Filed: 2018-09-06
Abstract: The invention relates to a transport device for transporting piece goods in a transport direction, comprising at least one transport element, which forms a closed loop and is driven in a circulating manner. The essential aspect according to the transport device is that a transport route section directly adjoining the at least one drive assembly in the circulation direction of the transport chain has at least a transition section and a back-up section, the at least one drive assembly being designed for sliding the chain links relative to each other in the transition section and for at least partially driving the already slid chain links in the back-up section.
Patent MX-2020005777-A (MX)
Title: Composition based on probiotics and uses thereof.
Inventor: BIFFI ANDREA
IPC: A61Q19/00
Filed: 2018-12-06
Abstract: The present invention relates to a composition comprising probiotics, preferably based on bacteria, in particular of the genus Lactobacillus, to be used for the purpose of preventing and/or treating the disorders affecting the skin, in particular inflammatory disorders, in particular autoinflammatory disorders of dermatological interest such as atopic dermatitis. Furthermore, the composition of the invention is useful for preventing and/or reducing the damage induced by UV radiation, in particular skin aging.
Patent MX-2020007516-A (MX)
Title: Clamping device.
Inventor: GIEMZA LEE
IPC: F16G11/10
Filed: 2019-01-29
Abstract: A clamping device (10) for clamping an elongate article (100) is disclosed. The damping device (10) comprises a body (12) and a clamping arrangement (26) in the body (12). The damping arrangement (26) comprises a clamping member (28) and an urging member (30) for urging the clamping member (2B) into clamping engagement with the elongate article (100). The body (12) has a reaction formation (56) along which the elongate article (100) can extend. The reaction formation (56) applies a reaction force to the elongate article (100) when so engaged by the clamping member (28). The clamping device (10) further includes a carriage (32) on which the damping member (28) is provided, and a release member (42) on the carriage (32) for releasing the damping member (28) from engagement with the elongate article (100). The release member (42) extends outwardly from the body (12).
Patent MX-2020007994-A (MX)
Title: Triazolopyrimidine derivatives for use as ghrelin o-acyl transferase (goat) inhibitors.
Inventor: HOENKE CHRISTOPH
IPC: A61K31/519
Filed: 2019-01-28
Abstract: The present invention relates to compounds of general formula I, wherein the groups R<sup>1</sup> and R<sup>2</sup> are defined as in claim 1, which have valuable pharmacological properties, in particular bind to ghrelin O-acyl transferase (GOAT) and modulate its activity. The compounds are suitable for treatment and prevention of diseases which can be influenced by this receptor, such as metabolic diseases, in particular obesity.
Patent MX-2020010873-A (MX)
Title: Lactuca sativa resistance to bremia lactucae.
Inventor: VEENSTRA ROELOF MARINUS
IPC: C12N15/82
Filed: 2020-10-14
Abstract: The current invention relates to a nucleic acid fragment comprising a resistance allele from L. serriola which confers a broad spectrum resistance to Bremia lactucae, wherein, said resistance allele co-segregates with one or more marker sequences chosen from Seq ID No. 1, Seq ID No. 2, Seq ID No. 3, Seq ID No. 4, Seq ID No. 5, Seq ID No. 6, Seq ID No. 7, and/or any L. serriola genome specific marker in between Seq ID No. 1 and Seq ID No. 7.
Patent MX-2020012490-A (MX)
Title: Process and formulation of polyamide polymeric bio compounds with natural fibers with a high concentration of organic compounds with low thermal stability.
Inventor: HERNÁNDEZ HERNÁNDEZ Ernesto
IPC: C08J5/06
Filed: 2020-11-20
Abstract: The present invention relates to the process and formulation of polymeric biocomposites, using natural fibers with a high concentration of organic compounds with a thermal stability of less than 200°C. Said process and formulation allow processing by the melt mixing method, avoiding fragmenting the natural fibers (FN) and maintaining their morphology. Also, it avoids using compatibilization or coupling agents to promote adhesion between the polyamide (PA) and the FN, observing adequate interfacial adhesion and compatibility between both phases (FN-PA). Further, it increases the crystallinity of the biocomposite at a micrometric scale, a unique advantage to this technology not possible to achieve with other processes reported in the state-of-the-art, reducing the polymeric matrices. The present invention relates to the polymer or plastic industry, construction, food, plastic recycling, and the automotive sector, among others.
Patent MX-2021002372-A (MX)
Title: Polymeric active ingredients which improve detergency.
Inventor: ETTL ROLAND
IPC: C11D1/00
Filed: 2019-08-08
Abstract: The aim of the invention is to improve the cleaning performance of detergents. This is achieved essentially by the use of amino-based alkoxylates.
Patent MX-2021002879-A (MX)
Title: Method for producing hydrated zinc hydrogen phosphate.
Inventor: KHALESS KHAOULA
IPC: C01B25/37
Filed: 2019-09-12
Abstract: The present invention relates to a method for producing hydrated zinc hydrogen phosphate (Zn<sub>3</sub>(HPO<sub>4</sub>)<sub>3</sub>, 3H<sub>2</sub>O) from zinc oxide ZnO and phosphoric acid H<sub>3</sub>PO<sub>4</sub>, mainly characterized in that it comprises the following steps: placing the phosphoric acid in a reactor, dissolving a determined quantity of zinc oxide in the phosphoric acid to form a reaction mixture, said determined quantity of zinc oxide being chosen so as to have a weight ratio between the phosphoric acid and the zinc oxide H<sub>3</sub>PO<sub>4</sub>/ZnO greater than or equal to 1, mechanically mixing the reaction mixture to form the hydrated zinc hydrogen phosphate.
Patent MX-2021002947-A (MX)
Title: Wicking element for aerosol delivery device.
Inventor: HEJAZI VAHID
IPC: A24F47/00
Filed: 2019-09-10
Abstract: An aerosol delivery device includes an outer housing, a reservoir containing a liquid, a heater configured to vaporize the liquid, and a liquid transport element configured to provide the liquid to the heater. The liquid transport element includes a rigid monolith. At least a portion of the rigid monolith is substantially cylindrical. The cylindrical portion has an exterior surface and a longitudinal axis. The exterior surface has at least one discontinuity.
Patent MX-2021006127-A (MX)
Title: Combination therapies for high and very high risk mds.
Inventor: GHALIE RICHARD
IPC: A61K31/706
Filed: 2019-11-26
Abstract: Provided herein are methods of treating high and very high risk MDS comprising administering pracinostat and a DNA hypomethylating agent. S.
Patent MX-2021008590-A (MX)
Title: Methods for characterizing disulfide bonds.
Inventor: WANG SHUNHAI
IPC: G01N1/28
Filed: 2020-01-16
Abstract: Compositions and methods for analyzing disulfide bonds are provided. An exemplary method includes preparing peptide standards having no disulfide bonds, scrambled disulfide bond peptide standards, and native disulfide bond peptide standards according to the sequence of the region of the protein drug product that includes the disulfide bond, digesting a sample of protein drug product into peptides, separating the protein drug product peptides, analyzing the protein drug product peptides and the peptide standards, identifying scrambled and native disulfide bond peptides by retention time, and quantifying the level of scrambled disulfide bond peptides.
Patent MX-2021009059-A (MX)
Title: Scouring pads.
Inventor: TUMAN SCOTT J
IPC: A47L17/08
Filed: 2020-01-28
Abstract: The present invention is a cleaning article including a fibrous filler and a wrapping at least partially surrounding the fibrous filler.
Patent MX-2021010052-A (MX)
Title: Collision energy absorption component for automobiles.
Inventor: SHIOZAKI TSUYOSHI
IPC: B60R19/34
Filed: 2019-12-12
Abstract: A collision energy absorption component 1 for automobiles according to the resent invention absorbs the collision energy by having a shaft that is crushed when a collision load is input from the front or rear of the automobile body. This collision energy absorption component 1 for automobiles comprises: a cylindrical member 3 which has a top board part 5a and a pair of vertical wall parts 5b; a closed cross-sectional space forming wall member 9 which is arranged within the cylindrical member 3 so as to straddle the top board part 5a, while having both ends bonded to the inner surfaces of the pair of vertical wall parts 5b, thereby forming a closed cross-sectional space between itself and the circumferential wall part of the cylindrical member 3; and a resin 11 which is filled into the closed cross-sectional space and contains a rubber-modified epoxy resin and a curing agent. The resin 11 has a tensile elongation at break of 80% or more, a bonding strength of 12 MPa or more between the cylindrical member 3 and the closed cross-sectional space forming wall member 9, and a nominal compressive stress of 6 MPa or more at a nominal compressive strain of 10%.
Patent MX-2021010990-A (MX)
Title: Shaped artificial polymer articles.
Inventor: DARJI RUPA HIREMATH
IPC: C04B35/453
Filed: 2020-03-09
Abstract: Use of porous metal oxide microspheres as light stabilizers for shaped artificial polymer articles, wherein the porous metal oxide microspheres are prepared via a process comprising forming a liquid dispersion of polymer nanoparticles and a metal oxide; forming liquid droplets of the dispersion; drying the droplets to provide polymer template microspheres comprising polymer nanospheres; and removing the polymer nanospheres from the template microspheres to provide the porous metal oxide microspheres.
Patent MX-2021012394-A (MX)
Title: Prophylactic efficacy of serotonin 4 receptor agonists against stress.
Inventor: DENNY CHRISTINE A
IPC: A61K31/138
Filed: 2020-04-08
Abstract: Methods for prophylactically treating a stress-induced affective disorder or stress-induced psychopathology in a subject are provided. Also provided are methods for inducing and/or enhancing stress resilience in a subject. In certain embodiments, an effective amount of an agonist of the serotonin 4 receptor (5-HT4R), or a pharmaceutically acceptable salt or derivative thereof, is administered to a subject prior to a stressor.
Patent MX-2022000022-A (MX)
Title: Improved hydrophobic aerogel materials.
Inventor: MELNIKOVA IRENE
IPC: C01B33/158
Filed: 2017-03-23
Abstract: The present disclosure provides an aerogel composition which is durable and easy to handle, which has favorable performance in aqueous environments, and which also has favorable combustion and self-heating properties. Also provided is a method of preparing an aerogel composition which is durable and easy to handle, which has favorable performance in aqueous environments, and which has favorable combustion and self-heating properties. Further provided is a method of improving the hydrophobicity, the liquid water uptake, the heat of combustion, or the onset of thermal decomposition temperature of an aerogel composition.
Patent MX-2022002183-A (MX)
Title: Cannabinoid acid ester compositions and uses thereof.
Inventor: SWISA RESHEF
IPC: A61K31/352
Filed: 2020-06-19
Abstract: The present disclosure provides pharmaceutical compositions including a cannabinoid acid ester compound alone or in combination with one or more additional cannabinoid compounds. In some embodiments, the cannabinoid acid ester compound is a tetrahydrocannabinolic acid (THCA) ester. In some embodiments, the cannabinoid acid ester compound is a cannabigerolic (CBGA) acid ester. In some embodiments, the cannabinoid acid ester compound is a cannabinolic (CBNA) acid ester. A variety of therapeutic applications in which the cannabinoid acid ester compounds and pharmaceutical compositions find use are also provided, including combination therapies using cannabinoid acid ester compounds and one or more additional therapeutic agents.
Patent MX-2022002244-A (MX)
Title: Method for identifying responders to smarca2/4 degraders.
Inventor: SASMAL SANJITA
IPC: C12Q1/6886
Filed: 2020-09-11
Abstract: The present invention relates to a method of treating a disease or disorder with at least one SMARCA2/4 degrader, in a subject who are responders to such treatment based on the presence of tumor specific alterations described therein. The present invention also provides the methods for treating prostate cancer in the subjects who are likely to respond to treatment with SMARCA2/4 degraders.
Patent MX-2022003180-A (MX)
Title: Surgical instruments with articulatable end effectors and movable firing beam support arrangements.
Inventor: HARRIS JASON L
IPC: A61B17/072
Filed: 2017-06-16
Abstract: A surgical instrument that includes a surgical end effector that is coupled to a shaft assembly by an articulation joint. A flexible firing beam extends through the articulation joint to interface with a firing member in the surgical end effector to apply a firing motion thereto. In at least one form, the surgical instrument further includes a movable firing beam support assembly that is configured to movably contact the firing beam on each lateral side thereof as the firing beam flexes about the articulation joint.
Patent MX-2022003619-A (MX)
Title: Surface enhanced pulp fibers, methods of making surface enhanced pulp fibers, products incorporating surface enhanced pulp fibers, and methods of making products incorporating surface enhanced pulp fibers.
Inventor: MARCOCCIA BRUNO
IPC: D21B1/04
Filed: 2013-08-21
Abstract: Various embodiments of the present invention relate to surface enhanced pulp fibers, various products incorporating surface enhanced pulp fibers, and methods and systems for producing surface enhanced pulp fibers. Various embodiments of surface enhanced pulp fibers have significantly increased surface areas compared to conventional refined fibers while advantageously minimizing reductions in length following refinement. The surface enhanced pulp fibers can be incorporated into a number of products that might benefit from such properties including, for example, paper products, paperboard products, fiber cement boards, fiber reinforced plastics, fluff pulps, hydrogels, cellulose acetate products, and carboxymethyl cellulose products. In some embodiments, a plurality of surface enhanced pulp fibers have a length weighted average fiber length of at least about 0.3 millimeters and an average hydrodynamic specific surface area of at least about 10 square meters per gram, wherein the number of surface enhanced pulp fibers is at least 12,000 fibers/milligram on an oven-dry basis.
Patent MX-2022004943-A (MX)
Title: Systems and approaches for drug delivery.
Inventor: SCHNEIDER MICHAEL
IPC: G01N24/08
Filed: 2020-10-23
Abstract: An approach for determining material compatibility for components of a drug delivery system is provided that includes using surface zeta-potential analytical method to evaluate surface interactions between a desired molecule and at least one material present within a given IV-bag system.
Patent MX-2022008013-A (MX)
Title: Stabilization of fc-containing polypeptides.
Inventor: KANNAN GUNASEKARAN
IPC: C07K16/00
Filed: 2016-01-27
Abstract: This disclosure provides polypeptides comprising an antibody Fc region having a deletion of one or more cysteine residues in the hinge region and substitution with a sulfhydryl-containing residue of one or more CH3-inteface amino acids. Also, provided are Fc-fusion proteins and antibodies containing said polypeptides, nucleic acids and vectors encoding said polypeptides, along with host cells and methods for making said polypeptides.
Patent MX-2022011012-A (MX)
Title: Modified short interfering nucleic acid (sina) molecules and uses thereof.
Inventor: HOSSBACH MARKUS
IPC: C12N15/113
Filed: 2021-03-05
Abstract: Disclosed herein are short interfering nucleic acid (siNA) molecules comprising modified nucleotides and uses thereof. The siNA molecules may be double stranded and comprise modified nucleotides selected from 2' -O-methyl nucleotides and 2' -fluoro nucleotides. Further disclosed herein are siNA molecules comprising (a) a phosphorylation blocker, conjugated moiety, or 5' -stabilized end cap; and (b) a short interfering nucleic acid (siNA).
Patent MX-2022011039-A (MX)
Title: Class ii, type v crispr systems.
Inventor: BROWN CHRISTOPHER
IPC: C12N9/22
Filed: 2021-03-06
Abstract: Described herein are methods, compositions, and systems derived from uncultivated microorganisms useful for gene editing.
Patent MX-2022013509-A (MX)
Title: Tire tracking rfid label.
Inventor: JANKO PAVEL
IPC: G06K19/077
Filed: 2017-03-28
Abstract: Identification labels and their incorporation in rubber-based articles are described. The labels include RFID components and can be incorporated in tires. The labels can withstand the relatively harsh conditions associated with vulcanization.